PRNewswire - Thursday November 30, 2000

"This is happening at a critical time for AIDS research," said Jerome Radwin, chief executive officer of amfAR. "The AIDS epidemic is ravaging populations and economies in many parts of the world. Here in the United States, HIV transmission rates are increasing among African Americans, Hispanics, women and young people. The epidemic is far from over."

Radwin added, "The funding that amfAR receives from this campaign will support the vital research needed to develop better treatments, new methods of rebuilding damaged immune systems, new methods of prevention and, ultimately, a safe and effective vaccine."

"We are committed to leveraging our core technology to aid in philanthropic endeavors," said West Shell III, CEO and chairman of Netcentives (Nasdaq: NCNT - news). "By using ClickMiles to generate support for AIDS research funding, we are driving significant Web traffic and donations towards an important social cause."

About AIDS

AIDS has replaced tuberculosis as the world's deadliest infectious disease among adults and is now the fourth leading cause of death worldwide. As we begin the 21st century, more than one million Americans are living with HIV -- nearly one of every 250 people. At least 40,000 Americans are newly infected each year, and half of these new infections occur among young people ages 15 to 24. Globally, there are over 34 million people living with HIV/AIDS, and more than 13 million children have been orphaned by the epidemic.

Thanks to new treatments, some people with HIV/AIDS are living longer, and the annual number of AIDS-related deaths in the U.S. has dropped in recent years. But the rate of this decline has slowed markedly and some regions are reporting an increase in AIDS deaths. Additional research is urgently needed to develop new techniques for preventing HIV infection, as well as better treatments and methods to restore immune system function.

About amfAR

amfAR is the nation's leading nonprofit organization dedicated to the support of AIDS research, AIDS prevention, treatment education, and the advocacy of sound AIDS-related public policy. Since 1985, amfAR has invested nearly $175 million in support for its programs and awarded grants to over 1,850 research teams worldwide. For more information, visit www.amfar.org or call 800-39-AMFAR. Netcentives' Cause-Marketing Solutions

Through a suite of technology products and services, Netcentives provides nonprofits with timely and compelling email marketing and incentives solutions that drive online donations and Web traffic.

Since its inception less than one year ago, Netcentives' Cause-Marketing Solutions group has produced more than a dozen successful fundraising campaigns for important social causes including, World Wildlife Fund, CARE, Toys for Tots and the Special Olympics.

About Netcentives Inc.

San Francisco-based Netcentives Inc., a leading provider of loyalty and direct marketing solutions, delivers a broad suite of relationship marketing technology and services including business, consumer and employee loyalty programs, customized email marketing and consulting services. With a global customer base approaching 300 companies, and over 40 million managed relationships, Netcentives' patented business processes and scalable technology infrastructure provide clients with the power and flexibility to drive enduring customer relationships both online and offline. For more information about Netcentives and its portfolio of relationship marketing solutions, visit www.netcentives.com or call 415-538-1888.

NOTE: Netcentives and ClickMiles are trademarks of Netcentives Inc. Other product and company names herein may be trademarks of their respective owners. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, regarding Netcentives' business strategy and future plans of operations. Forward-looking statements involve known and unknown risks and uncertainties, both general and specific to the matters discussed in this press release. These and other important factors, including those mentioned in various Securities and Exchange Commission filings made periodically by Netcentives, may cause Netcentives' actual results and performance to differ materially from the future results and performance expressed in or implied by such forward-looking statements. The forward-looking statements contained in this press release speak only as of the date hereof and Netcentives expressly disclaims any obligation to provide public updates, revisions or amendments to any forward- looking statements made herein to reflect changes in Netcentives' expectations or future events.

SOURCE: Netcentives Inc.
001130
PR001134

Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .